Baxter International

In 1931 was created Baxter International, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Deerfield. The fund was located in North America if to be more exact in United States.

The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2013. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Baxter International works on 4 percentage points less the average amount of lead investments.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Baxter International, startups are often financed by Versant Ventures, Seroba Life Sciences, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are Sunstone Life Science Ventures, Roche Venture Fund, Novartis Venture Fund. In the next rounds fund is usually obtained by Takeda Ventures, Takeda Pharmaceutical, Sunstone Life Science Ventures.

Among the most successful fund investment fields, there are Medical, Therapeutics. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Gliknik, Opsona, Ocular Therapeutix. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Notable deals

Review

• No reviews are submitted yet.